.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard
Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. It is available from four suppliers. There is one patent protecting this drug.

This drug has twenty-one patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin phosphate. There are fifty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for Tradename: CLEOCIN

Patents:1
Applicants:1
NDAs:14
Suppliers / Packagers: see list4
Drug Prices: :see details

Pharmacology for Tradename: CLEOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
CLEOCIN
clindamycin hydrochloride
CAPSULE;ORAL061809-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Pharmacia And Upjohn
CLEOCIN T
clindamycin phosphate
LOTION;TOPICAL050600-001May 31, 1989RXYes► subscribe► subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
CREAM;VAGINAL050680-001Aug 11, 1992DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CLEOCIN

Country Document Number Estimated Expiration
Hong Kong1047538► subscribe
Portugal1200065► subscribe
Australia6219800► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CLEOCIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992/01Switzerland► subscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
401Luxembourg► subscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
2013025,C1304992Lithuania► subscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc